| Jenna Herring, | |
|
806 Hay St, Fayetteville, NC 28305-5312 | |
| (910) 860-7008 | |
| (910) 221-9006 |
| Full Name | Jenna Herring |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 806 Hay St, Fayetteville, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023399102 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TF0200X | Psychologist - Forensic | 5712 (North Carolina) | Secondary |
| 103TC0700X | Psychologist - Clinical | 5712 (North Carolina) | Primary |
| Entity Name | Haymount Institute For Psychological Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528239993 PECOS PAC ID: 1153498415 Enrollment ID: O20080929000365 |
News Archive
The results of the much awaited BEAUTIFUL (morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with CAD and left ventricULar dysfunction) trial have shown that coronary artery disease (CAD) patients with left ventricular dysfunction (LVD) and a heart rate more than 70 bpm have a significantly higher risk of cardiovascular death and other cardiovascular events and in these patients (heart rate above 70 bpm) treatment with ivabradine further reduces the risk of the most important coronary events such as fatal and non-fatal myocardial infarction and coronary revascularisation by one third, even when these patients are already receiving optimal therapy.
The U.S. Food and Drug Administration today approved Marqibo (vincristine sulfate liposome injection) to treat adults with a rare type of leukemia called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). ALL is a rapidly progressing form of blood and bone marrow cancer that is more commonly diagnosed in children than adults.
Questions have been raised in the U.S. over the safety and effectiveness of a hormone based drug which is used in women who have a history of pre-term births.
Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which the Company will acquire Atritech, a privately held company based in Plymouth, Minnesota.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jenna Herring, 806 Hay St, Fayetteville, NC 28305-5312 Ph: (910) 860-7008 | Jenna Herring, 806 Hay St, Fayetteville, NC 28305-5312 Ph: (910) 860-7008 |
News Archive
The results of the much awaited BEAUTIFUL (morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with CAD and left ventricULar dysfunction) trial have shown that coronary artery disease (CAD) patients with left ventricular dysfunction (LVD) and a heart rate more than 70 bpm have a significantly higher risk of cardiovascular death and other cardiovascular events and in these patients (heart rate above 70 bpm) treatment with ivabradine further reduces the risk of the most important coronary events such as fatal and non-fatal myocardial infarction and coronary revascularisation by one third, even when these patients are already receiving optimal therapy.
The U.S. Food and Drug Administration today approved Marqibo (vincristine sulfate liposome injection) to treat adults with a rare type of leukemia called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). ALL is a rapidly progressing form of blood and bone marrow cancer that is more commonly diagnosed in children than adults.
Questions have been raised in the U.S. over the safety and effectiveness of a hormone based drug which is used in women who have a history of pre-term births.
Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which the Company will acquire Atritech, a privately held company based in Plymouth, Minnesota.
› Verified 5 days ago
Dr. Mary Beth Barnes, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2300 Ramsey St, Ms 116, Fayetteville, NC 28301 Phone: 910-488-2120 Fax: 910-822-7934 | |
Theodore W. Lane, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1540 Purdue Dr Ste 200, Fayetteville, NC 28303 Phone: 910-867-8889 Fax: 910-487-3061 | |
Dr. Tiffany Nicole Gatling, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 2300 Ramsey St, Fayetteville, NC 28301 Phone: 910-488-2120 | |
Miss Liandra Mercedis Wheeler, LPA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2940 Breezewood Ave, Fayetteville, NC 28303 Phone: 910-827-6594 Fax: 910-827-6592 | |
Dr. Paul J Dean, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 874 Long Iron Dr, Fayetteville, NC 28312 Phone: 910-960-7510 | |
Mrs. Nicole O Collins, M.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5843 Waters Edge Dr, Fayetteville, NC 28314 Phone: 732-642-4412 |